Sierra Oncology, Inc: Q4 Earnings Snapshot

March 10, 2022 GMT

SAN MATEO, Calif. (AP) _ Sierra Oncology, Inc (SRRA) on Thursday reported a loss of $25.5 million in its fourth quarter.

On a per-share basis, the San Mateo, California-based company said it had a loss of $1.67.

The results did not meet Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of $1.60 per share.

For the year, the company reported a loss of $94.7 million, or $7.14 per share.


This story was generated by Automated Insights ( using data from Zacks Investment Research. Access a Zacks stock report on SRRA at